Clinical Trials in Tororo, Uganda
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Sickle Cell Disease
Novartis Pharmaceuticals315 enrolled31 locationsNCT06439082
Recruiting
Phase 1
Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
Healthy Volunteers
Gates Medical Research Institute123 enrolled2 locationsNCT06408857
Recruiting
Phase 2
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals327 enrolled12 locationsNCT05750628